Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
3.45M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
1.78M
-
Shares change
-
+2.89K
-
Total reported value, excl. options
-
$7.8M
-
Value change
-
-$314K
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$4.39
Significant Holders of IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) as of Q4 2021
15 filings reported holding INAB - IN8BIO, INC. - Common Stock, $0.0001 par value per share as of Q4 2021.
IN8BIO, INC. - Common Stock, $0.0001 par value per share (INAB) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.78M shares
of 3.45M outstanding shares and own 51.52% of the company stock.
Largest 10 shareholders include Capital World Investors (800K shares), Nantahala Capital Management, LLC (373K shares), B. Riley Financial, Inc. (257K shares), VANGUARD GROUP INC (120K shares), Voss Capital, LLC (102K shares), Ensign Peak Advisors, Inc (70K shares), Sigma Planning Corp (28.6K shares), HighTower Advisors, LLC (10K shares), BlackRock Inc. (9.56K shares), and Tower Research Capital LLC (TRC) (3.18K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.